Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.007 Å; R factor = 0.037; wR factor = 0.080; data-to-parameter ratio = 17.1.
In the title compound, [Cd 2 I 4 (C 24 H 22 N 4 ) 2 ], the 1,3-bis[(2-methyl-1H-benzimidazol-1-yl)methyl]benzene ligand bridges two CdI 2 units, forming a centrosymmetric dinuclear complex. The Cd II atom adopts a distorted tetrahedral coordination geometry. In the crystal, complex molecules are linked into columns parallel to [101] by -stacking interactions, with centroid-centroid distances of 3.558 (2) Å . et al., 2006; Yu et al., 2010; Li et al., 2011; Dobrzanska et al., 2006) .
Related literature
The asymmetric unit of the title compound consists of a CdI 2 unit and a 2-methyl-1Hbenzimidazol-1-yl)methyl]benzene molecule, where the ligand bridges two metal atoms forming a centrosymmetric dinuclear complex molecule ( 
Experimental
To a solution of CdI 2 (0.02 mmol, 0.0073 g) in methanol (5 ml) an equivalent amount of the ligand 2-methyl-1H-benzimidazol-1-yl)methyl]benzene in DMF (1 ml) was added. After three weeks, stick-shaped colourless crystals were obtained on slow evaporation of the solvents at room temperature.
Refinement
H atoms were positioned geometrically and refined using a riding model, With C-H = 0.93 Å (CH), 0.97 Å (CH 2 ), 0.96 Å (CH 3 ), and with U iso = 1.2 U eq (C) or 1.5 U eq (C) for methyl H atoms.
Figures Fig. 1 . The molecular structure of the title complex, showing 30% probability displacement ellipsoids. Hydrogen atoms are omitted for clarity. Atoms labelled with suffix A are generated by the symmetry operation (1-x, -y, 1-z).
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